Minimum inhibitory concentrations of cephalosporin compounds and their active metabolites for selected mastitis pathogens

Abstract

Differences in inhibition between parent compounds and their active metabolites may be responsible for some of the variation between clinical outcomes and results of in vitro susceptibility tests.